Literature DB >> 6864481

Solubility of hydrocortisone in organic and aqueous media: evidence for regular solution behavior in apolar solvents.

T A Hagen, G L Flynn.   

Abstract

The solubility of hydrocortisone was determined experimentally in a wide variety of solvents. Groups of solvents were selected to emphasize different solute-solvent interactions which can influence the solubility profile of such a large, polyfunctional solute. Regular solution theory for a crystalline solute was shown to be applicable to the solubility behavior of hydrocortisone in solvents that lack strong dipoles and the ability to hydrogen bond. A best-fit solubility parameter of 12.4 (cal/ml)1/2 for hydrocortisone was determined from the latter solubilities and the ideal solubility of hydrocortisone. This solubility parameter estimate was significantly higher than estimates calculated from molar-attraction constants. Even though molar volume ratios between hydrocortisone and the solvents ranged from 2.25 to 3.28, the associated Flory-Huggins entropy term did not seem to be a significant solubility-determining factor. In all cases, the solubility of hydrocortisone in solvents capable of dipole-dipole interactions and hydrogen bonding was shown to be higher by logarithmic orders when compared with regular solution theory predictions. Thus, for this solute, regular solution theory was shown to be appropriate only for solvents where London dispersion forces dominate the interactions between solute and solvent molecules.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6864481     DOI: 10.1002/jps.2600720422

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

1.  Solubility and related physicochemical properties of narcotic analgesics.

Authors:  S D Roy; G L Flynn
Journal:  Pharm Res       Date:  1988-09       Impact factor: 4.200

2.  Differential molar heat capacities to test ideal solubility estimations.

Authors:  S H Neau; S V Bhandarkar; E W Hellmuth
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

3.  Population Pharmacokinetics of Vamorolone (VBP15) in Healthy Men and Boys With Duchenne Muscular Dystrophy.

Authors:  Panteleimon D Mavroudis; John van den Anker; Laurie S Conklin; Jesse M Damsker; Eric P Hoffman; Kanneboyina Nagaraju; Paula R Clemens; William J Jusko
Journal:  J Clin Pharmacol       Date:  2019-02-11       Impact factor: 3.126

4.  Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin.

Authors:  S D Roy; G L Flynn
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

5.  Cosolvency and deviations from log-linear solubilization.

Authors:  J T Rubino; S H Yalkowsky
Journal:  Pharm Res       Date:  1987-06       Impact factor: 4.200

6.  Glyceride lipid formulations: molecular dynamics modeling of phase behavior during dispersion and molecular interactions between drugs and excipients.

Authors:  Dallas B Warren; Dylan King; Hassan Benameur; Colin W Pouton; David K Chalmers
Journal:  Pharm Res       Date:  2013-10-03       Impact factor: 4.200

7.  Solid and liquid heat capacities of n-alkyl para-aminobenzoates near the melting point.

Authors:  S H Neau; G L Flynn
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

8.  The effect of temperature and pH on the solubility of quinolone compounds: estimation of heat of fusion.

Authors:  X Yu; G L Zipp; G W Davidson
Journal:  Pharm Res       Date:  1994-04       Impact factor: 4.200

9.  A quantitative structure-property relationship for predicting drug solubility in PEG 400/water cosolvent systems.

Authors:  Erik Rytting; Kimberley A Lentz; Xue-Qing Chen; Feng Qian; Srini Venkatesh
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

10.  Flash nanoprecipitation: prediction and enhancement of particle stability via drug structure.

Authors:  Zhengxi Zhu
Journal:  Mol Pharm       Date:  2014-02-12       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.